BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 32166495)

  • 1. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
    Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective evaluation of the value of dynamic contrast enhanced (DCE) imaging for prostate cancer detection, with pathology correlation.
    Al Salmi I; Menezes T; El-Khodary M; Monteiro S; Haider EA; Alabousi A
    Can J Urol; 2020 Jun; 27(3):10220-10227. PubMed ID: 32544044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head-to-head comparison of biparametric versus multiparametric MRI of the prostate before robot-assisted transperineal fusion prostate biopsy.
    Thaiss WM; Moser S; Hepp T; Kruck S; Rausch S; Scharpf M; Nikolaou K; Stenzl A; Bedke J; Kaufmann S
    World J Urol; 2022 Oct; 40(10):2431-2438. PubMed ID: 35922717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically Significant Prostate Cancer Detection After a Negative Prebiopsy MRI Examination: Comparison of Biparametric Versus Multiparametric MRI.
    Gan JM; Kikano EG; Smith DA; Rao S; Podury R; Wang M; Durieux JC; Paspulati RM; Ponsky L; Ramaiya NH; Tirumani SH
    AJR Am J Roentgenol; 2022 May; 218(5):859-866. PubMed ID: 34817189
    [No Abstract]   [Full Text] [Related]  

  • 9. Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial.
    Wallström J; Geterud K; Kohestani K; Maier SE; Månsson M; Pihl CG; Socratous A; Arnsrud Godtman R; Hellström M; Hugosson J
    Eur Radiol; 2021 Nov; 31(11):8692-8702. PubMed ID: 33890152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit of dynamic contrast-enhanced (DCE) imaging for prostate cancer detection depending on readers experience in prostate MRI.
    Ziayee F; Schimmöller L; Boschheidgen M; Kasprowski L; Al-Monajjed R; Quentin M; Radtke JP; Albers P; Antoch G; Ullrich T
    Clin Radiol; 2024 Mar; 79(3):e468-e474. PubMed ID: 38185579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of biparametric versus multiparametric prostate MRI for the detection of extracapsular extension and seminal vesicle invasion in biopsy naïve patients.
    Caglic I; Sushentsev N; Shah N; Warren AY; Lamb BW; Barrett T
    Eur J Radiol; 2021 Aug; 141():109804. PubMed ID: 34062473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biparametric vs multiparametric prostate magnetic resonance imaging for the detection of prostate cancer in treatment-naïve patients: a diagnostic test accuracy systematic review and meta-analysis.
    Alabousi M; Salameh JP; Gusenbauer K; Samoilov L; Jafri A; Yu H; Alabousi A
    BJU Int; 2019 Aug; 124(2):209-220. PubMed ID: 30929292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol.
    Asif A; Nathan A; Ng A; Khetrapal P; Chan VW; Giganti F; Allen C; Freeman A; Punwani S; Lorgelly P; Clarke CS; Brew-Graves C; Muirhead N; Emberton M; Agarwal R; Takwoingi Y; Deeks JJ; Moore CM; Kasivisvanathan V;
    BMJ Open; 2023 Apr; 13(4):e070280. PubMed ID: 37019486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
    Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
    World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of the diagnostic accuracy of biparametric prostate MRI for prostate cancer in men at risk.
    Bass EJ; Pantovic A; Connor M; Gabe R; Padhani AR; Rockall A; Sokhi H; Tam H; Winkler M; Ahmed HU
    Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):596-611. PubMed ID: 33219368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the equivalent performance of biparametric compared to multiparametric MRI in detection of clinically significant prostate cancer.
    Wang B; Gao J; Zhang Q; Zhang C; Liu G; Wei W; Huang H; Fu Y; Li D; Zhang B; Guo H
    Abdom Radiol (NY); 2020 Feb; 45(2):547-555. PubMed ID: 31907568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
    Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
    Eur J Radiol; 2020 Nov; 132():109350. PubMed ID: 33080549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
    Choi MH; Kim CK; Lee YJ; Jung SE
    AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Predictive Value of Biparametric Prostate Magnetic Resonance Imaging in Excluding Significant Prostate Cancer: A Pooled Data Analysis Based on Clinical Data from Four Prospective, Registered Studies.
    Knaapila J; Jambor I; Ettala O; Taimen P; Verho J; Perez IM; Kiviniemi A; Pahikkala T; Merisaari H; Lamminen T; Saunavaara J; Aronen HJ; Syvänen KT; Boström PJ
    Eur Urol Focus; 2021 May; 7(3):522-531. PubMed ID: 32418878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.